Versaflex™ CE 3320-70 is the first of its kind and only blue jean stain resistant thermoplastic elastomer for white and light-colored phone cases. Reduce overall costs – Versaflex CE 3320-70 has lower manufacturing and total part costs compared to silicone. VERSAFLEX CE 3320-70 Color Clear Hardness 70 Tensile Strength (PSI) 1788 Elongation % 373 www.avient.com Copyright © 2020, Avient Corporation.

GILMOUR® A Q U A A R M O R T M L I G H T W E I G H T H O S E • Lightweight • Improved kink resistance and flexibility • Soft yet durable solution for consumer appeal • Shelf differentiation • Drinking water safe • Met all requirements with a custom TPE solution, enabling Gilmour to produce a more compact hose about 50% lighter than standard PVC hoses • Incorporated custom colorants for brand consistency, and specialty additives for enhanced UV and abrasion resistance • Delivered a single-material solution for easier manufacturing, and supplied materials locally to align with customer’s “Made in the USA” brand • Provided regulatory and technical support to product development Customized Versaflex™ TPE KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers

MEDICAL TUBING EXTRUDER B I O P H A R M A C E U T I C A L T U B I N G • Low leachables & extractables • Great tensile performance and kink resistance • Good thermal weldability • Excellent clarity and medical blue tint • ISO 10993-4 & 5, USP Class VI & Animal Derivative Free (ADF) • Supplied drop-in material replacement to overcome supply constraints of incumbent TPE • Offered a lower extractable profile than comparable materials in the market • Enabled easy material transition without changes in tooling or thermal welding machine settings • Formulated solution with proprietary additives to provide clarity and prevent yellowing after sterilization Versaflex™ HC BT218 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers

O RT H O P E D I C PA RT S M A N U FAC T U R E R O R T H O P E D I C S O L E I N S E R T • A super soft TPE ( AVIENT SOLUTION HAPTICS + BIOCOMPATIBILITY LEARN MORE © 2024 Avient Corporation, All Rights Reserved https://www.avient.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. GUIDANCE DEBT / LEVERAGE R EDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End 4 Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 20 22 TRA NSF OR MATI ONAL PORTFOLI O ENHA NC EMENTS 5 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio G ROW I NG C OM PO SI T ES P LAT F OR M C O NT R I BU TI O NS TO S EM S EG ME NT 6 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites 9% C O M P O S I T E S P O R T F O L I O D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 7 ADVA NC ED C OM POSI TES PERFORMA NCE 8 (1) Pro forma for the acquisition of Avient Protective Materials Sales $51 $84 $212 $668 2016 2018 2020 2022 $4 $10 $41 $169 2016 2018 2020 2022 EBITDA (1) (1) ($ in millions) PORTFOLIO EVOLUTION AND EPS EXPANSION 9 Adj. EBITDA Margins (1) 5.4% 11.5% 16.2% 2006 2018 2022PF $142 $408 $592 2006 2018 2022PF 2006 figures exclude joint venture results 2022 pro forma for the acquisition of Avient Protective Materials Adj.

Versaflex™ CF Low Adhesive Build-up TPE for Protective Film Tack Layer Protective films guard the surface of finished goods from initial fabrication through assembly, shipment, storage, and installation. Versaflex™ CF 6668 low adhesion build-up TPE for protective film meets that need. Compared to current solvent- based coating technology, co-extrusion film using Versaflex CF has significantly reduced volatile organic compound (VOC) emissions and helps reduce energy consumption by eliminating secondary coating and drying operations.

PMMA Considering lens performance, Resilience™ LS Frost PVC offers properties and material performance similar to PMMA, often at a significantly lower cost. 1 ASTM D-1003 measured by Polymer Diagnostics, Inc. PolyOne makes no warranties or guarantees respecting suitability of either PolyOne’s products or the information for your process or end-use application. POLYONE MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. W H AT W E D O : M AT E R I A L S C I E N C E 5 CUSTOM FORMULATION F E B R U A R Y 1 5 , 2 0 2 3 W E B C A S T Q4 2022 VS. GUIDANCE DEBT / LEVERAGE R EDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End 8 Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 20 22 TRA NSF OR MATI ONAL PORTFOLI O ENHA NC EMENTS 9 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio G ROW I NG C OM PO SI T ES P LAT F OR M C O NT R I BU TI O NS TO S EM S EG ME NT 10 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites 9% C O M P O S I T E S P O R T F O L I O D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 11 ADVA NC ED C OM POSI TES PERFORMA NCE 12 (1) Pro forma for the acquisition of Avient Protective Materials Sales $51 $84 $212 $668 2016 2018 2020 2022 $4 $10 $41 $169 2016 2018 2020 2022 EBITDA (1) (1) ($ in millions) PORTFOLIO EVOLUTION AND EPS EXPANSION 13 Adj.

Versaflex™ HC Thermoplastic Elastomers Disinfectant Resistant Trilliant™ and Versaflex™ HC Materials Healthcare TPEs: Versaflex™ HC

Versaflex™ HC and Versaflex HC BIO Thermoplastic Elastomers (TPEs): These specialty TPE formulations offer versatile and customizable performance for medical and biopharmaceutical tubing, device overmolds, and injection molded applications. Available in a variety of durometers and performance characteristics, the product family includes grades formulated without animal derivatives and a bio-based Versaflex HC BIO BT218 formulation developed specifically to handle the complexities of biopharmaceutical tubing (excellent weldability, kink resistance, and low levels of leachables and extractables) with a lower carbon footprint than traditional Versaflex HC TPE or silicone alternatives.